Pomalidomide 4 MG

DRUG2 trials

Sponsors

Kosin University Gospel Hospital, Nanjing University School of Medicine

Conditions

Light Chain (AL) AmyloidosisRelapsed and/or refractorY Multiple Myeloma

Phase 2

The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)

CompletedNCT03242460

Kosin University Gospel HospitalRelapsed and/or refractorY Multiple Myeloma

Start: 2015-05-12End: 2019-05-02Updated: 2020-02-20

Unknown Phase

Daratumumab for Patients With Light Chain Amyloidosis

RecruitingNCT06376214

Nanjing University School of MedicineLight Chain (AL) Amyloidosis

Start: 2023-01-01End: 2026-12-31Target: 100Updated: 2024-04-19